The FDA has approved Keytruda in combination with pemetrexed and platinum chemotherapy, as first-line Tx of unresectable advanced or metastatic malignant pleural mesothelioma.
Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious ...
The FDA has approved Merck's Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for first-line ...
Drug major Merck & Co., Inc. (MRK) announced Wednesday that the U.S. Food and Drug Administration has approved its anti-PD-1 therapy ...
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time ...
“The combination of NC410 and pembrolizumab continues to demonstrate clinical activity ... and Exchange Commission (the “SEC”), including NextCure’s most recent Form 10-K and subsequent Form 10-Q. You ...
Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following ...
Pharmac’s Director of Pharmaceuticals, Geraldine MacGibbon, says Pharmac is really pleased to announce our first decision for cancer medicines since the Government provided additional funding in June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback